Cargando…
P1112: PATIENT-REPORTED OUTCOMES (PRO) AMONG PATIENTS WITH MANTLE CELL LYMPHOMA RECEIVING PIRTOBRUTINIB AFTER PRIOR COVALENT BTKI: INTERIM PRO ANALYSIS FROM THE BRUIN PHASE 1/2 STUDY
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431003/ http://dx.doi.org/10.1097/01.HS9.0000971344.34270.c5 |
| _version_ | 1785091095319805952 |
|---|---|
| author | Cohen, Jonathon Roeker, Lindsey Cheah, Chan Eyre, Toby Patel, Krish Woyach, Jennifer Seymour, John Wang, Michael Wang, Yucai Loubert, Angely Payakachat, Nalin Hess, Lisa Abada, Paolo Mato, Anthony R. Ghia, Paolo |
| author_facet | Cohen, Jonathon Roeker, Lindsey Cheah, Chan Eyre, Toby Patel, Krish Woyach, Jennifer Seymour, John Wang, Michael Wang, Yucai Loubert, Angely Payakachat, Nalin Hess, Lisa Abada, Paolo Mato, Anthony R. Ghia, Paolo |
| author_sort | Cohen, Jonathon |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10431003 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104310032023-08-17 P1112: PATIENT-REPORTED OUTCOMES (PRO) AMONG PATIENTS WITH MANTLE CELL LYMPHOMA RECEIVING PIRTOBRUTINIB AFTER PRIOR COVALENT BTKI: INTERIM PRO ANALYSIS FROM THE BRUIN PHASE 1/2 STUDY Cohen, Jonathon Roeker, Lindsey Cheah, Chan Eyre, Toby Patel, Krish Woyach, Jennifer Seymour, John Wang, Michael Wang, Yucai Loubert, Angely Payakachat, Nalin Hess, Lisa Abada, Paolo Mato, Anthony R. Ghia, Paolo Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431003/ http://dx.doi.org/10.1097/01.HS9.0000971344.34270.c5 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Cohen, Jonathon Roeker, Lindsey Cheah, Chan Eyre, Toby Patel, Krish Woyach, Jennifer Seymour, John Wang, Michael Wang, Yucai Loubert, Angely Payakachat, Nalin Hess, Lisa Abada, Paolo Mato, Anthony R. Ghia, Paolo P1112: PATIENT-REPORTED OUTCOMES (PRO) AMONG PATIENTS WITH MANTLE CELL LYMPHOMA RECEIVING PIRTOBRUTINIB AFTER PRIOR COVALENT BTKI: INTERIM PRO ANALYSIS FROM THE BRUIN PHASE 1/2 STUDY |
| title | P1112: PATIENT-REPORTED OUTCOMES (PRO) AMONG PATIENTS WITH MANTLE CELL LYMPHOMA RECEIVING PIRTOBRUTINIB AFTER PRIOR COVALENT BTKI: INTERIM PRO ANALYSIS FROM THE BRUIN PHASE 1/2 STUDY |
| title_full | P1112: PATIENT-REPORTED OUTCOMES (PRO) AMONG PATIENTS WITH MANTLE CELL LYMPHOMA RECEIVING PIRTOBRUTINIB AFTER PRIOR COVALENT BTKI: INTERIM PRO ANALYSIS FROM THE BRUIN PHASE 1/2 STUDY |
| title_fullStr | P1112: PATIENT-REPORTED OUTCOMES (PRO) AMONG PATIENTS WITH MANTLE CELL LYMPHOMA RECEIVING PIRTOBRUTINIB AFTER PRIOR COVALENT BTKI: INTERIM PRO ANALYSIS FROM THE BRUIN PHASE 1/2 STUDY |
| title_full_unstemmed | P1112: PATIENT-REPORTED OUTCOMES (PRO) AMONG PATIENTS WITH MANTLE CELL LYMPHOMA RECEIVING PIRTOBRUTINIB AFTER PRIOR COVALENT BTKI: INTERIM PRO ANALYSIS FROM THE BRUIN PHASE 1/2 STUDY |
| title_short | P1112: PATIENT-REPORTED OUTCOMES (PRO) AMONG PATIENTS WITH MANTLE CELL LYMPHOMA RECEIVING PIRTOBRUTINIB AFTER PRIOR COVALENT BTKI: INTERIM PRO ANALYSIS FROM THE BRUIN PHASE 1/2 STUDY |
| title_sort | p1112: patient-reported outcomes (pro) among patients with mantle cell lymphoma receiving pirtobrutinib after prior covalent btki: interim pro analysis from the bruin phase 1/2 study |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431003/ http://dx.doi.org/10.1097/01.HS9.0000971344.34270.c5 |
| work_keys_str_mv | AT cohenjonathon p1112patientreportedoutcomesproamongpatientswithmantlecelllymphomareceivingpirtobrutinibafterpriorcovalentbtkiinterimproanalysisfromthebruinphase12study AT roekerlindsey p1112patientreportedoutcomesproamongpatientswithmantlecelllymphomareceivingpirtobrutinibafterpriorcovalentbtkiinterimproanalysisfromthebruinphase12study AT cheahchan p1112patientreportedoutcomesproamongpatientswithmantlecelllymphomareceivingpirtobrutinibafterpriorcovalentbtkiinterimproanalysisfromthebruinphase12study AT eyretoby p1112patientreportedoutcomesproamongpatientswithmantlecelllymphomareceivingpirtobrutinibafterpriorcovalentbtkiinterimproanalysisfromthebruinphase12study AT patelkrish p1112patientreportedoutcomesproamongpatientswithmantlecelllymphomareceivingpirtobrutinibafterpriorcovalentbtkiinterimproanalysisfromthebruinphase12study AT woyachjennifer p1112patientreportedoutcomesproamongpatientswithmantlecelllymphomareceivingpirtobrutinibafterpriorcovalentbtkiinterimproanalysisfromthebruinphase12study AT seymourjohn p1112patientreportedoutcomesproamongpatientswithmantlecelllymphomareceivingpirtobrutinibafterpriorcovalentbtkiinterimproanalysisfromthebruinphase12study AT wangmichael p1112patientreportedoutcomesproamongpatientswithmantlecelllymphomareceivingpirtobrutinibafterpriorcovalentbtkiinterimproanalysisfromthebruinphase12study AT wangyucai p1112patientreportedoutcomesproamongpatientswithmantlecelllymphomareceivingpirtobrutinibafterpriorcovalentbtkiinterimproanalysisfromthebruinphase12study AT loubertangely p1112patientreportedoutcomesproamongpatientswithmantlecelllymphomareceivingpirtobrutinibafterpriorcovalentbtkiinterimproanalysisfromthebruinphase12study AT payakachatnalin p1112patientreportedoutcomesproamongpatientswithmantlecelllymphomareceivingpirtobrutinibafterpriorcovalentbtkiinterimproanalysisfromthebruinphase12study AT hesslisa p1112patientreportedoutcomesproamongpatientswithmantlecelllymphomareceivingpirtobrutinibafterpriorcovalentbtkiinterimproanalysisfromthebruinphase12study AT abadapaolo p1112patientreportedoutcomesproamongpatientswithmantlecelllymphomareceivingpirtobrutinibafterpriorcovalentbtkiinterimproanalysisfromthebruinphase12study AT matoanthonyr p1112patientreportedoutcomesproamongpatientswithmantlecelllymphomareceivingpirtobrutinibafterpriorcovalentbtkiinterimproanalysisfromthebruinphase12study AT ghiapaolo p1112patientreportedoutcomesproamongpatientswithmantlecelllymphomareceivingpirtobrutinibafterpriorcovalentbtkiinterimproanalysisfromthebruinphase12study |